0 XP   0   0   0

DR.REDDY'S LABORATORIES LTD.
Buy, Hold or Sell?

Should you buy, hold or sell DR.REDDY'S LABORATORIES LTD.?

I guess you are interested in DR.REDDY'S LABORATORIES LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse DR.REDDY'S LABORATORIES LTD.

Let's start. I'm going to help you getting a better view of DR.REDDY'S LABORATORIES LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is DR.REDDY'S LABORATORIES LTD. even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how DR.REDDY'S LABORATORIES LTD. is doing in the market. If the company is worth buying. The latest step is to find out how other investors value DR.REDDY'S LABORATORIES LTD.. The closing price on 2023-02-03 was INR4,358 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
DR.REDDY'S LABORATORIES LTD. Daily Candlestick Chart
DR.REDDY'S LABORATORIES LTD. Daily Candlestick Chart
Summary









1. Valuation of DR.REDDY'S LABORATORIES LTD.




Current price per share

INR4,357.90

2. Growth of DR.REDDY'S LABORATORIES LTD.




Is DR.REDDY'S LABORATORIES LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$2.5b$2.1b$246.7m10.2%

How much money is DR.REDDY'S LABORATORIES LTD. making?

Current yearPrevious yearGrowGrow %
Making money$94.8m$59.8m$35m36.9%
Net Profit Margin13.8%9.3%--

How much money comes from the company's main activities?

3. Financial Health of DR.REDDY'S LABORATORIES LTD.




Comparing to competitors in the Pharmaceuticals industry




  Industry Rankings (Pharmaceuticals)  


Richest
#3 / 53

Most Profit
#10 / 53


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of DR.REDDY'S LABORATORIES LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit DR.REDDY'S LABORATORIES LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare DR.REDDY'S LABORATORIES LTD. to the Pharmaceuticals industry mean.
  • A Net Profit Margin of 17.6% means that ₹0.18 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of DR.REDDY'S LABORATORIES LTD.:

  • The MRQ is 17.6%. The company is making a huge profit. +2
  • The TTM is 13.8%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ17.6%TTM13.8%+3.8%
TTM13.8%YOY9.3%+4.6%
TTM13.8%5Y11.2%+2.7%
5Y11.2%10Y10.4%+0.7%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ17.6%3.3%+14.3%
TTM13.8%6.9%+6.9%
YOY9.3%9.9%-0.6%
5Y11.2%6.3%+4.9%
10Y10.4%6.7%+3.7%
1.1.2. Return on Assets

Shows how efficient DR.REDDY'S LABORATORIES LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare DR.REDDY'S LABORATORIES LTD. to the Pharmaceuticals industry mean.
  • 3.8% Return on Assets means that DR.REDDY'S LABORATORIES LTD. generated ₹0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of DR.REDDY'S LABORATORIES LTD.:

  • The MRQ is 3.8%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.7%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.8%TTM2.7%+1.2%
TTM2.7%YOY1.8%+0.9%
TTM2.7%5Y2.4%+0.3%
5Y2.4%10Y2.1%+0.2%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ3.8%0.8%+3.0%
TTM2.7%1.3%+1.4%
YOY1.8%1.5%+0.3%
5Y2.4%1.4%+1.0%
10Y2.1%1.4%+0.7%
1.1.3. Return on Equity

Shows how efficient DR.REDDY'S LABORATORIES LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare DR.REDDY'S LABORATORIES LTD. to the Pharmaceuticals industry mean.
  • 5.4% Return on Equity means DR.REDDY'S LABORATORIES LTD. generated ₹0.05 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of DR.REDDY'S LABORATORIES LTD.:

  • The MRQ is 5.4%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 3.9%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ5.4%TTM3.9%+1.5%
TTM3.9%YOY2.7%+1.2%
TTM3.9%5Y3.6%+0.3%
5Y3.6%10Y3.1%+0.5%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ5.4%1.5%+3.9%
TTM3.9%2.0%+1.9%
YOY2.7%3.0%-0.3%
5Y3.6%2.1%+1.5%
10Y3.1%2.0%+1.1%

1.2. Operating Efficiency of DR.REDDY'S LABORATORIES LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient DR.REDDY'S LABORATORIES LTD. is operating .

  • Measures how much profit DR.REDDY'S LABORATORIES LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare DR.REDDY'S LABORATORIES LTD. to the Pharmaceuticals industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of DR.REDDY'S LABORATORIES LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y7.2%-7.2%
5Y7.2%10Y7.7%-0.5%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ--5.6%+5.6%
TTM-0.5%-0.5%
YOY-6.2%-6.2%
5Y7.2%5.1%+2.1%
10Y7.7%5.2%+2.5%
1.2.2. Operating Ratio

Measures how efficient DR.REDDY'S LABORATORIES LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • An Operation Ratio of 1.03 means that the operating costs are ₹1.03 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of DR.REDDY'S LABORATORIES LTD.:

  • The MRQ is 1.031. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.124. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.031TTM1.124-0.093
TTM1.124YOY1.171-0.046
TTM1.1245Y1.131-0.007
5Y1.13110Y1.183-0.051
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0311.342-0.311
TTM1.1241.276-0.152
YOY1.1711.169+0.002
5Y1.1311.149-0.018
10Y1.1831.178+0.005

1.3. Liquidity of DR.REDDY'S LABORATORIES LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if DR.REDDY'S LABORATORIES LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A Current Ratio of 2.16 means the company has ₹2.16 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of DR.REDDY'S LABORATORIES LTD.:

  • The MRQ is 2.160. The company is able to pay all its short-term debts. +1
  • The TTM is 1.989. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.160TTM1.989+0.172
TTM1.989YOY1.804+0.185
TTM1.9895Y1.828+0.160
5Y1.82810Y1.715+0.113
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1602.205-0.045
TTM1.9892.010-0.021
YOY1.8042.125-0.321
5Y1.8281.812+0.016
10Y1.7151.786-0.071
1.3.2. Quick Ratio

Measures if DR.REDDY'S LABORATORIES LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare DR.REDDY'S LABORATORIES LTD. to the Pharmaceuticals industry mean.
  • A Quick Ratio of 1.61 means the company can pay off ₹1.61 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of DR.REDDY'S LABORATORIES LTD.:

  • The MRQ is 1.609. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.276. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.609TTM1.276+0.333
TTM1.276YOY1.102+0.174
TTM1.2765Y1.196+0.080
5Y1.19610Y1.098+0.099
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6091.118+0.491
TTM1.2761.152+0.124
YOY1.1021.091+0.011
5Y1.1961.007+0.189
10Y1.0980.869+0.229

1.4. Solvency of DR.REDDY'S LABORATORIES LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of DR.REDDY'S LABORATORIES LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare DR.REDDY'S LABORATORIES LTD. to Pharmaceuticals industry mean.
  • A Debt to Asset Ratio of 0.29 means that DR.REDDY'S LABORATORIES LTD. assets are financed with 28.8% credit (debt) and the remaining percentage (100% - 28.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of DR.REDDY'S LABORATORIES LTD.:

  • The MRQ is 0.288. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.323. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.288TTM0.323-0.035
TTM0.323YOY0.340-0.017
TTM0.3235Y0.342-0.019
5Y0.34210Y0.366-0.023
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2880.381-0.093
TTM0.3230.379-0.056
YOY0.3400.417-0.077
5Y0.3420.398-0.056
10Y0.3660.399-0.033
1.4.2. Debt to Equity Ratio

Measures if DR.REDDY'S LABORATORIES LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare DR.REDDY'S LABORATORIES LTD. to the Pharmaceuticals industry mean.
  • A Debt to Equity ratio of 40.4% means that company has ₹0.40 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of DR.REDDY'S LABORATORIES LTD.:

  • The MRQ is 0.404. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.479. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.404TTM0.479-0.075
TTM0.479YOY0.517-0.038
TTM0.4795Y0.525-0.046
5Y0.52510Y0.540-0.015
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4040.586-0.182
TTM0.4790.598-0.119
YOY0.5170.598-0.081
5Y0.5250.671-0.146
10Y0.5400.664-0.124

2. Market Valuation of DR.REDDY'S LABORATORIES LTD.

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings DR.REDDY'S LABORATORIES LTD. generates.

  • Above 15 is considered overpriced but always compare DR.REDDY'S LABORATORIES LTD. to the Pharmaceuticals industry mean.
  • A PE ratio of 64.68 means the investor is paying ₹64.68 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of DR.REDDY'S LABORATORIES LTD.:

  • The EOD is 65.038. Neutral. Compare to industry.
  • The MRQ is 64.681. Neutral. Compare to industry.
  • The TTM is 244.862. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD65.038MRQ64.681+0.357
MRQ64.681TTM244.862-180.181
TTM244.862YOY888.730-643.868
TTM244.8625Y349.368-104.507
5Y349.36810Y335.010+14.359
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD65.03840.785+24.253
MRQ64.68151.661+13.020
TTM244.86251.419+193.443
YOY888.73064.495+824.235
5Y349.36856.903+292.465
10Y335.01061.712+273.298
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of DR.REDDY'S LABORATORIES LTD..

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of DR.REDDY'S LABORATORIES LTD.:

  • The MRQ is 69.023. Seems overpriced? -1
  • The TTM is 1,407.147. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ69.023TTM1,407.147-1,338.124
TTM1,407.147YOY21,546.643-20,139.496
TTM1,407.1475Y6,605.657-5,198.511
5Y6,605.65710Y5,688.778+916.879
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ69.0230.015+69.008
TTM1,407.1470.036+1,407.111
YOY21,546.6430.327+21,546.316
5Y6,605.6570.144+6,605.513
10Y5,688.7780.144+5,688.634

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of DR.REDDY'S LABORATORIES LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A PB ratio of 3.47 means the investor is paying ₹3.47 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of DR.REDDY'S LABORATORIES LTD.:

  • The EOD is 3.488. Neutral. Compare to industry.
  • The MRQ is 3.469. Neutral. Compare to industry.
  • The TTM is 3.786. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD3.488MRQ3.469+0.019
MRQ3.469TTM3.786-0.317
TTM3.786YOY4.702-0.915
TTM3.7865Y4.296-0.510
5Y4.29610Y4.148+0.148
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD3.4882.248+1.240
MRQ3.4692.690+0.779
TTM3.7863.050+0.736
YOY4.7023.185+1.517
5Y4.2962.899+1.397
10Y4.1482.711+1.437
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of DR.REDDY'S LABORATORIES LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--44.27933.539+32%28.220+57%36.904+20%69.410-36%
Book Value Growth--1.0371.029+1%1.027+1%1.0400%1.034+0%
Book Value Per Share--1249.3731187.916+5%1066.497+17%978.786+28%925.103+35%
Book Value Per Share Growth--1.0371.029+1%1.027+1%1.051-1%1.043-1%
Current Ratio--2.1601.989+9%1.804+20%1.828+18%1.715+26%
Debt To Asset Ratio--0.2880.323-11%0.340-15%0.342-16%0.366-21%
Debt To Equity Ratio--0.4040.479-16%0.517-22%0.525-23%0.540-25%
Dividend Per Share--29.94313.719+118%12.468+140%11.943+151%13.290+125%
Eps--67.00546.741+43%29.489+127%33.479+100%29.803+125%
Eps Growth--0.9373.511-73%5.828-84%3.311-72%3.061-69%
Free Cash Flow Per Share--35.79432.859+9%-2.028+106%22.016+63%19.457+84%
Free Cash Flow Per Share Growth--4.9253.256+51%4.554+8%3.148+56%2.853+73%
Free Cash Flow To Equity Per Share---103.401-25.676-75%-17.877-83%0.012-866122%-1.520-99%
Free Cash Flow To Equity Per Share Growth--0.660-0.107+116%0.316+109%0.044+1414%0.226+192%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--9290.439--------
Intrinsic Value_10Y_min--732.269--------
Intrinsic Value_1Y_max--247.514--------
Intrinsic Value_1Y_min--81.055--------
Intrinsic Value_3Y_max--1264.551--------
Intrinsic Value_3Y_min--238.331--------
Intrinsic Value_5Y_max--2909.560--------
Intrinsic Value_5Y_min--388.696--------
Net Profit Margin--0.1760.138+27%0.093+89%0.112+58%0.104+69%
Operating Margin----0%-0%0.072-100%0.077-100%
Operating Ratio--1.0311.124-8%1.171-12%1.131-9%1.183-13%
Pb Ratio3.488+1%3.4693.786-8%4.702-26%4.296-19%4.148-16%
Pe Ratio65.038+1%64.681244.862-74%888.730-93%349.368-81%335.010-81%
Peg Ratio--69.0231407.147-95%21546.643-100%6605.657-99%5688.778-99%
Price Per Share4357.900+1%4333.9504486.975-3%5006.413-13%4157.936+4%3828.564+13%
Price To Total Gains Ratio58.714+1%58.392110.827-47%246.795-76%99.470-41%97.359-40%
Profit Growth--0.9373.511-73%5.828-84%3.505-73%3.220-71%
Quick Ratio--1.6091.276+26%1.102+46%1.196+35%1.098+47%
Return On Assets--0.0380.027+43%0.018+114%0.024+61%0.021+80%
Return On Equity--0.0540.039+38%0.027+98%0.036+49%0.031+73%
Revenue Growth--1.2101.028+18%1.045+16%1.091+11%1.072+13%
Total Gains Per Share--74.22247.258+57%40.688+82%48.847+52%82.700-10%
Total Gains Per Share Growth--1.4931.154+29%2.830-47%2.631-43%2.240-33%
Usd Book Value--2534574400.0002410357050.000+5%2163578500.000+17%2100608200.000+21%1966152677.778+29%
Usd Book Value Change Per Share--0.5400.409+32%0.344+57%0.450+20%0.847-36%
Usd Book Value Per Share--15.24214.493+5%13.011+17%11.941+28%11.286+35%
Usd Dividend Per Share--0.3650.167+118%0.152+140%0.146+151%0.162+125%
Usd Eps--0.8170.570+43%0.360+127%0.408+100%0.364+125%
Usd Free Cash Flow--72614400.00066691300.000+9%-4114450.000+106%31474257.143+131%24479977.778+197%
Usd Free Cash Flow Per Share--0.4370.401+9%-0.025+106%0.269+63%0.237+84%
Usd Free Cash Flow To Equity Per Share---1.261-0.313-75%-0.218-83%0.000-866122%-0.019-99%
Usd Price Per Share53.166+1%52.87454.741-3%61.078-13%50.727+4%46.708+13%
Usd Profit--135932400.00094839750.000+43%59822700.000+127%76665671.429+77%67264700.000+102%
Usd Revenue--772479600.000682525950.000+13%623484050.000+24%640329200.000+21%592999977.778+30%
Usd Total Gains Per Share--0.9060.577+57%0.496+82%0.596+52%1.009-10%
 EOD+2 -3MRQTTM+34 -6YOY+33 -75Y+31 -1010Y+28 -13

3.2. Fundamental Score

Let's check the fundamental score of DR.REDDY'S LABORATORIES LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1565.038
Price to Book Ratio (EOD)Between0-13.488
Net Profit Margin (MRQ)Greater than00.176
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.609
Current Ratio (MRQ)Greater than12.160
Debt to Asset Ratio (MRQ)Less than10.288
Debt to Equity Ratio (MRQ)Less than10.404
Return on Equity (MRQ)Greater than0.150.054
Return on Assets (MRQ)Greater than0.050.038
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of DR.REDDY'S LABORATORIES LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.942
Ma 20Greater thanMa 504,317.910
Ma 50Greater thanMa 1004,347.582
Ma 100Greater thanMa 2004,350.965
OpenGreater thanClose4,371.000
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in INR. All numbers in thousands.

Summary
Total Assets291,689,000
Total Liabilities83,937,000
Total Stockholder Equity207,752,000
 As reported
Total Liabilities 83,937,000
Total Stockholder Equity+ 207,752,000
Total Assets = 291,689,000

Assets

Total Assets291,689,000
Total Current Assets172,542,000
Long-term Assets172,542,000
Total Current Assets
Cash And Cash Equivalents 9,096,000
Short-term Investments 21,215,000
Net Receivables 76,987,000
Inventory 49,042,000
Other Current Assets 16,202,000
Total Current Assets  (as reported)172,542,000
Total Current Assets  (calculated)172,542,000
+/-0
Long-term Assets
Property Plant Equipment 63,280,000
Goodwill 5,224,000
Long Term Investments 6,107,000
Intangible Assets 31,589,000
Other Assets 8,202,000
Long-term Assets  (as reported)115,368,000
Long-term Assets  (calculated)114,402,000
+/- 966,000

Liabilities & Shareholders' Equity

Total Current Liabilities79,867,000
Long-term Liabilities4,718,000
Total Stockholder Equity207,752,000
Total Current Liabilities
Short-term Debt 14,573,000
Short Long Term Debt 14,573,000
Accounts payable 22,778,000
Other Current Liabilities 35,812,000
Total Current Liabilities  (as reported)79,867,000
Total Current Liabilities  (calculated)87,736,000
+/- 7,869,000
Long-term Liabilities
Long term Debt Total 1,795,000
Capital Lease Obligations 2,716,000
Long-term Liabilities  (as reported)4,718,000
Long-term Liabilities  (calculated)4,511,000
+/- 207,000
Total Stockholder Equity
Common Stock832,000
Retained Earnings 206,920,000
Total Stockholder Equity (as reported)207,752,000
Total Stockholder Equity (calculated)207,752,000
+/-0
Other
Capital Stock832,000
Cash And Equivalents9,096,000
Cash and Short Term Investments 30,311,000
Common Stock Shares Outstanding 166,018
Liabilities and Stockholders Equity 291,689,000
Net Debt 5,477,000
Net Invested Capital 220,798,000
Net Working Capital 95,575,000



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
227,188,000
219,821,000
218,387,000
222,018,000
225,956,000
233,142,000
217,898,000
232,253,000
251,243,000
253,802,000
252,346,000
266,168,000
278,214,000
279,210,000
282,499,000
297,469,000
295,975,000
291,689,000
291,689,000295,975,000297,469,000282,499,000279,210,000278,214,000266,168,000252,346,000253,802,000251,243,000232,253,000217,898,000233,142,000225,956,000222,018,000218,387,000219,821,000227,188,000
   > Total Current Assets 
105,363,000
100,375,000
100,007,000
103,008,000
109,491,000
120,085,000
117,254,000
130,370,000
132,937,000
132,800,000
133,418,000
145,503,000
158,776,000
160,098,000
166,829,000
177,823,000
179,708,000
172,542,000
172,542,000179,708,000177,823,000166,829,000160,098,000158,776,000145,503,000133,418,000132,800,000132,937,000130,370,000117,254,000120,085,000109,491,000103,008,000100,007,000100,375,000105,363,000
       Cash And Cash Equivalents 
6,031,000
3,866,000
2,825,000
2,460,000
2,010,000
3,012,000
2,244,000
2,053,000
4,400,000
3,889,000
4,321,000
14,829,000
8,168,000
9,980,000
21,976,000
14,852,000
6,018,000
9,096,000
9,096,0006,018,00014,852,00021,976,0009,980,0008,168,00014,829,0004,321,0003,889,0004,400,0002,053,0002,244,0003,012,0002,010,0002,460,0002,825,0003,866,0006,031,000
       Short-term Investments 
14,114,000
14,270,000
11,748,000
14,333,000
19,948,000
25,540,000
17,505,000
23,687,000
23,291,000
21,154,000
11,530,000
21,602,000
20,331,000
16,721,000
13,224,000
31,087,000
28,324,000
21,215,000
21,215,00028,324,00031,087,00013,224,00016,721,00020,331,00021,602,00011,530,00021,154,00023,291,00023,687,00017,505,00025,540,00019,948,00014,333,00011,748,00014,270,00014,114,000
       Net Receivables 
42,724,000
44,999,000
44,657,000
45,931,000
46,471,000
43,649,000
47,394,000
57,309,000
49,069,000
50,077,000
53,165,000
49,641,000
61,022,000
68,611,000
62,446,000
66,764,000
73,214,000
76,987,000
76,987,00073,214,00066,764,00062,446,00068,611,00061,022,00049,641,00053,165,00050,077,00049,069,00057,309,00047,394,00043,649,00046,471,00045,931,00044,657,00044,999,00042,724,000
       Inventory 
30,052,000
28,529,000
28,095,000
26,998,000
26,825,000
35,033,000
37,746,000
35,066,000
39,148,000
41,134,000
44,309,000
45,412,000
50,771,000
49,700,000
49,675,000
50,884,000
51,810,000
49,042,000
49,042,00051,810,00050,884,00049,675,00049,700,00050,771,00045,412,00044,309,00041,134,00039,148,00035,066,00037,746,00035,033,00026,825,00026,998,00028,095,00028,529,00030,052,000
       Other Current Assets 
12,442,000
7,999,000
12,682,000
13,286,000
14,237,000
12,851,000
12,365,000
11,305,000
17,029,000
13,736,000
16,059,000
14,019,000
15,042,000
15,086,000
13,995,000
14,236,000
16,206,000
16,202,000
16,202,00016,206,00014,236,00013,995,00015,086,00015,042,00014,019,00016,059,00013,736,00017,029,00011,305,00012,365,00012,851,00014,237,00013,286,00012,682,0007,999,00012,442,000
   > Long-term Assets 
0
0
0
0
0
113,776,000
100,644,000
101,871,000
118,306,000
118,371,000
118,928,000
117,242,000
119,438,000
115,228,000
115,670,000
110,971,000
116,267,000
115,368,000
115,368,000116,267,000110,971,000115,670,000115,228,000119,438,000117,242,000118,928,000118,371,000118,306,000101,871,000100,644,000113,776,00000000
       Property Plant Equipment 
0
57,160,000
57,611,000
57,905,000
58,189,000
53,008,000
52,709,000
52,332,000
54,183,000
54,737,000
0
56,861,000
0
59,939,000
0
61,665,000
0
63,280,000
63,280,000061,665,000059,939,000056,861,000054,737,00054,183,00052,332,00052,709,00053,008,00058,189,00057,905,00057,611,00057,160,0000
       Goodwill 
3,789,000
3,752,000
3,824,000
3,883,000
3,870,000
4,605,000
3,939,000
4,913,000
4,817,000
5,626,000
4,634,000
5,599,000
4,615,000
5,614,000
4,546,000
5,473,000
4,381,000
5,224,000
5,224,0004,381,0005,473,0004,546,0005,614,0004,615,0005,599,0004,634,0005,626,0004,817,0004,913,0003,939,0004,605,0003,870,0003,883,0003,824,0003,752,0003,789,000
       Long Term Investments 
7,389,000
6,840,000
5,366,000
4,831,000
5,014,000
4,217,000
3,278,000
3,091,000
3,387,000
3,992,000
8,632,000
8,333,000
9,496,000
7,489,000
6,491,000
7,986,000
5,214,000
6,107,000
6,107,0005,214,0007,986,0006,491,0007,489,0009,496,0008,333,0008,632,0003,992,0003,387,0003,091,0003,278,0004,217,0005,014,0004,831,0005,366,0006,840,0007,389,000
       Intangible Assets 
0
44,925,000
44,740,000
45,751,000
44,312,000
39,222,000
26,908,000
26,798,000
41,174,000
40,394,000
36,428,000
35,248,000
35,131,000
32,329,000
32,035,000
27,011,000
31,832,000
31,589,000
31,589,00031,832,00027,011,00032,035,00032,329,00035,131,00035,248,00036,428,00040,394,00041,174,00026,798,00026,908,00039,222,00044,312,00045,751,00044,740,00044,925,0000
       Other Assets 
0
6,769,000
6,839,000
6,640,000
5,080,000
12,211,000
13,810,000
14,795,000
14,745,000
13,026,000
0
10,993,000
0
9,745,000
0
13,399,000
0
8,202,000
8,202,000013,399,00009,745,000010,993,000013,026,00014,745,00014,795,00013,810,00012,211,0005,080,0006,640,0006,839,0006,769,0000
> Total Liabilities 
106,148,000
95,777,000
94,964,000
100,178,000
102,271,000
79,026,000
69,226,000
76,265,000
89,495,000
87,128,000
82,951,000
89,751,000
100,100,000
93,766,000
92,483,000
105,345,000
95,586,000
83,937,000
83,937,00095,586,000105,345,00092,483,00093,766,000100,100,00089,751,00082,951,00087,128,00089,495,00076,265,00069,226,00079,026,000102,271,000100,178,00094,964,00095,777,000106,148,000
   > Total Current Liabilities 
95,281,000
85,000,000
65,520,000
70,339,000
73,198,000
61,176,000
64,694,000
72,814,000
79,884,000
78,007,000
73,872,000
81,038,000
91,525,000
85,259,000
83,654,000
97,658,000
90,791,000
79,867,000
79,867,00090,791,00097,658,00083,654,00085,259,00091,525,00081,038,00073,872,00078,007,00079,884,00072,814,00064,694,00061,176,00073,198,00070,339,00065,520,00085,000,00095,281,000
       Short-term Debt 
57,999,000
49,185,000
50,462,000
53,667,000
54,911,000
10,308,000
0
16,532,000
0
19,953,000
0
23,145,000
0
23,380,000
0
27,082,000
0
14,573,000
14,573,000027,082,000023,380,000023,145,000019,953,000016,532,000010,308,00054,911,00053,667,00050,462,00049,185,00057,999,000
       Short Long Term Debt 
57,999,000
49,185,000
50,462,000
53,667,000
54,911,000
15,621,000
14,467,000
20,315,000
24,049,000
19,953,000
13,110,000
23,145,000
26,299,000
23,380,000
21,331,000
27,082,000
21,701,000
14,573,000
14,573,00021,701,00027,082,00021,331,00023,380,00026,299,00023,145,00013,110,00019,953,00024,049,00020,315,00014,467,00015,621,00054,911,00053,667,00050,462,00049,185,00057,999,000
       Accounts payable 
13,308,000
13,417,000
13,225,000
14,193,000
14,575,000
15,434,000
17,810,000
10,745,000
19,038,000
22,833,000
23,072,000
12,696,000
28,607,000
25,552,000
24,492,000
15,971,000
25,052,000
22,778,000
22,778,00025,052,00015,971,00024,492,00025,552,00028,607,00012,696,00023,072,00022,833,00019,038,00010,745,00017,810,00015,434,00014,575,00014,193,00013,225,00013,417,00013,308,000
       Other Current Liabilities 
29,691,000
8,910,000
26,393,000
27,431,000
28,173,000
29,481,000
31,810,000
12,819,000
36,053,000
29,927,000
31,530,000
2,385,000
30,872,000
30,999,000
31,435,000
2,503,000
36,666,000
35,812,000
35,812,00036,666,0002,503,00031,435,00030,999,00030,872,0002,385,00031,530,00029,927,00036,053,00012,819,00031,810,00029,481,00028,173,00027,431,00026,393,0008,910,00029,691,000
   > Long-term Liabilities 
0
0
0
0
0
18,869,000
4,532,000
4,439,000
9,611,000
9,471,000
9,079,000
9,038,000
8,575,000
8,670,000
8,829,000
8,285,000
4,795,000
4,718,000
4,718,0004,795,0008,285,0008,829,0008,670,0008,575,0009,038,0009,079,0009,471,0009,611,0004,439,0004,532,00018,869,00000000
       Long term Debt Total 
0
0
0
0
0
15,284,000
0
1,304,000
0
6,661,000
0
6,299,000
0
5,977,000
0
5,746,000
0
1,795,000
1,795,00005,746,00005,977,00006,299,00006,661,00001,304,000015,284,00000000
       Other Liabilities 
0
5,328,000
4,884,000
4,887,000
4,612,000
3,585,000
3,286,000
3,135,000
2,822,000
2,810,000
0
0
0
0
0
0
0
0
000000002,810,0002,822,0003,135,0003,286,0003,585,0004,612,0004,887,0004,884,0005,328,0000
> Total Stockholder Equity
0
124,044,000
123,423,000
121,840,000
123,685,000
154,116,000
148,672,000
155,988,000
161,748,000
166,674,000
169,395,000
176,417,000
178,114,000
185,444,000
190,016,000
192,124,000
200,389,000
207,752,000
207,752,000200,389,000192,124,000190,016,000185,444,000178,114,000176,417,000169,395,000166,674,000161,748,000155,988,000148,672,000154,116,000123,685,000121,840,000123,423,000124,044,0000
   Common Stock
8,158,000
829,000
829,000
829,000
829,000
831,000
831,000
831,000
831,000
831,000
0
832,000
0
832,000
0
832,000
0
832,000
832,0000832,0000832,0000832,0000831,000831,000831,000831,000831,000829,000829,000829,000829,0008,158,000
   Retained Earnings Total Equity000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000
   Capital Surplus 000000000000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
0
7,632,000
6,451,000
5,804,000
4,268,000
3,266,000
3,770,000
2,421,000
3,139,000
3,245,000
0
0
0
0
0
0
0
0
000000003,245,0003,139,0002,421,0003,770,0003,266,0004,268,0005,804,0006,451,0007,632,0000



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue215,452,000
Cost of Revenue-79,972,000
Gross Profit135,480,000135,480,000
 
Operating Income (+$)
Gross Profit135,480,000
Operating Expense-178,472,000
Operating Income26,025,000-42,992,000
 
Operating Expense (+$)
Research Development17,482,000
Selling General Administrative73,399,000
Selling And Marketing Expenses-
Operating Expense178,472,00090,881,000
 
Net Interest Income (+$)
Interest Income2,813,000
Interest Expense-958,000
Net Interest Income7,0001,855,000
 
Pretax Income (+$)
Operating Income26,025,000
Net Interest Income7,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)30,614,00029,653,000
EBIT - interestExpense = -958,000
21,825,000
22,783,000
Interest Expense958,000
Earnings Before Interest and Taxes (ebit)-31,572,000
Earnings Before Interest and Taxes (ebitda)45,080,000
 
After tax Income (+$)
Income Before Tax30,614,000
Tax Provision-8,833,000
Net Income From Continuing Ops23,568,00021,781,000
Net Income21,825,000
Net Income Applicable To Common Shares21,825,000
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items44,000
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-3,628,000-7,000
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
ENLT.TA
3 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of ENLT.TA.

ENLT.TA Daily Candlestick Chart
GBPEUR.FOREX
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GBPEUR.FOREX.

GBPEUR.FOREX Daily Candlestick Chart
NZDPHP.FOREX
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NZDPHP.FOREX.

NZDPHP.FOREX Daily Candlestick Chart
NZDIDR.FOREX
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NZDIDR.FOREX.

NZDIDR.FOREX Daily Candlestick Chart
MYRGBP.FOREX
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MYRGBP.FOREX.

MYRGBP.FOREX Daily Candlestick Chart
GBPMYR.FOREX
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GBPMYR.FOREX.

GBPMYR.FOREX Daily Candlestick Chart
GBPIDR.FOREX
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GBPIDR.FOREX.

GBPIDR.FOREX Daily Candlestick Chart
SGDGBP.FOREX
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SGDGBP.FOREX.

SGDGBP.FOREX Daily Candlestick Chart
GBPSGD.FOREX
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GBPSGD.FOREX.

GBPSGD.FOREX Daily Candlestick Chart
CADNOK.FOREX
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CADNOK.FOREX.

CADNOK.FOREX Daily Candlestick Chart
SVRT.TA
7 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SVRT.TA.

SVRT.TA Daily Candlestick Chart
PHTM.TA
7 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PHTM.TA.

PHTM.TA Daily Candlestick Chart
NICE.TA
7 hours ago

I found you a Golden Cross on the daily chart of NICE.TA.

NICE.TA Daily Candlestick Chart
NFTA.TA
7 hours ago

I found you a MACD Bearish Hidden Divergence on the daily chart of NFTA.TA.

NFTA.TA Daily Candlestick Chart
ICB.TA
7 hours ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of ICB.TA.

ICB.TA Daily Candlestick Chart
FRSX.TA
7 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of FRSX.TA.

FRSX.TA Daily Candlestick Chart
DCMA.TA
7 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DCMA.TA.

DCMA.TA Daily Candlestick Chart
ARD.TA
7 hours ago

I found you a Death Cross on the daily chart of ARD.TA.

ARD.TA Daily Candlestick Chart
MCRNT.TA
9 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of MCRNT.TA.

MCRNT.TA Daily Candlestick Chart